Sensus Healthcare, Inc. (SRTS) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated November 14, 2024, announces the financial results for Sensus Healthcare, Inc. for the third quarter of 2024. The company is incorporated in Delaware and trades on the Nasdaq Stock Market under the symbol SRTS.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release filed as Exhibit 99.1, which is incorporated by reference but not included in the provided text. The filing notes that the press release includes non-GAAP financial measures and a reconciliation to GAAP figures.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. Investors must refer to the referenced press release (Exhibit 99.1) for comparative financial data and analysis of operational changes.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook, management commentary, or risk factors. It explicitly states that the information furnished under Item 2.02 and in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference in any filing under the Securities Act of 1933, except as expressly set forth by specific reference.
Key Facts for Investor Verification
- Verify the specific Q3 2024 revenue, net income, and cash flow figures in the press release (Exhibit 99.1).
- Review the reconciliation of non-GAAP financial measures provided in the press release.
- Confirm any forward-looking statements or guidance issued in the November 14, 2024 press release.
- Note that the 8-K filing itself serves as a notification of the results rather than a source of detailed financial data.